Induced Abortion in First Trimester Not Linked to Rh Sensitization
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 19, 2023 -- Induced first-trimester abortion is not associated with Rh sensitization, according to a study published online Sept. 26 in the Journal of the American Medical Association.
Sarah Horvath, M.D., from Penn State University College of Medicine in Hershey, and colleagues conducted a multicenter, observational, prospective cohort study to detect circulating fetal red blood cells (fRBCs) in paired maternal blood samples before and after induced first-trimester abortion. Paired blood samples were available for 506 participants who underwent medical or procedural abortion (63.0 and 37.0 percent, respectively).
The researchers found that three of the participants had elevated fRBC counts at baseline; one of these had an elevated fRBC count after abortion (0.2 percent). After induced first-trimester abortion, no other participants had elevated fRBC counts above the sensitization threshold. The median change from baseline in fRBC counts was 0, with upper 95th and 99th percentiles of 24.0 and 35.6 fRBCs, respectively. A strong association was seen between preabortion and postabortion fRBC counts, but no other baseline characteristic was associated with postabortion fRBC count.
"This evidence should inform the alignment of international guidelines and clinical care surrounding Rh immunoglobulin following first-trimester induced abortion," the authors write.
One author disclosed ties to Athenium Pharmaceuticals and has a patent for medical management of nonviable pregnancy.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Mail-Order Mifepristone Effective, Feasible for Medication Abortion
MONDAY, May 13, 2024 -- Mail-order pharmacy dispensing of mifepristone for medication abortion is effective, acceptable, and feasible, according to a study published online May 13...
Considerable Number of Abortion Seekers Accessed Services After Dobbs
MONDAY, March 25, 2024 -- Despite implementation of state-level bans and restrictions on abortion after the Supreme Court decision in Dobbs v. Jackson Women's Health Organization...
Imetelstat Leads to Durable Red Blood Cell Transfusion Independence
TUESDAY, Jan. 9, 2024 -- For heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.